Bristol-Myers Squibb Co banner

Bristol-Myers Squibb Co
NYSE:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
NYSE:BMY
Watchlist
Price: 59.98 USD -0.25% Market Closed
Market Cap: $122.1B

Wall Street
Price Targets

BMY Price Targets Summary
Bristol-Myers Squibb Co

Wall Street analysts forecast BMY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BMY is 62.03 USD with a low forecast of 33.43 USD and a high forecast of 78.75 USD.

Lowest
Price Target
33.43 USD
44% Downside
Average
Price Target
62.03 USD
3% Upside
Highest
Price Target
78.75 USD
31% Upside
Bristol-Myers Squibb Co Competitors:
Price Targets

Revenue
Forecast

6% / Year
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
6% / Year
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 14 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 6%. The projected CAGR for the next 3 years is -5%.

Operating Income
Forecast

7% / Year
Past Growth
-7% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
7% / Year
Past Growth
-7% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 14 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 7%. The projected CAGR for the next 3 years is -7%.

Net Income
Forecast

5% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-47%
Average Miss
5% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-47%
Average Miss

For the last 14 years the compound annual growth rate for Bristol-Myers Squibb Co's net income is 5%. The projected CAGR for the next 3 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BMY's stock price target?
Price Target
62.03 USD

According to Wall Street analysts, the average 1-year price target for BMY is 62.03 USD with a low forecast of 33.43 USD and a high forecast of 78.75 USD.

What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
-5%

For the last 14 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 6%. The projected CAGR for the next 3 years is -5%.

What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
-7%

For the last 14 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 7%. The projected CAGR for the next 3 years is -7%.

What is Bristol-Myers Squibb Co's Net Income forecast?
Projected CAGR
16%

For the last 14 years the compound annual growth rate for Bristol-Myers Squibb Co's net income is 5%. The projected CAGR for the next 3 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett